Ask AI
ProCE Banner Activity

The Ongoing Weight Debate: Using GLP-1 Receptor Agonists to Address Weight Gain in People Living With HIV

Conference Coverage
Clinical Thought

A substantial number of people living with HIV gain weight while receiving ART. What can we learn from the latest studies presented at IDWeek and EACS 2023 about strategies for managing weight, including ART switch and use of glucagon-like peptide-1 receptor agonists?

Released: November 08, 2023

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Faculty Disclosure

Primary Author

Darcy Wooten, MD, MS, FIDSA

Professor of Medicine
ID Fellowship Program Director
Associate Chief of Education
Director of Educational Initiatives
Division of Infectious Diseases
Washington University in St Louis
St Louis, Missouri

Darcy Wooten, MD, MS, has no relevant financial relationships to disclose.